Havas Lynx Group

What Havas Lynx Group does

Havas Lynx is a healthcare communications agency headquartered in Manchester, UK, operating as a wholly-owned subsidiary of Havas Health & You within the broader Havas global communications group. Founded in 1984, the agency employs nearly 500–600 multidisciplinary specialists across offices in Manchester, London, and New York, serving pharmaceutical companies, biotech firms, and healthcare brands with campaign development, brand strategy, medical education, HCP engagement, patient activation, clinical trial recruitment, and CX optimization. Its GTM is direct enterprise sales, with thought leadership (white papers, data reports, podcasts) used to drive top-of-funnel awareness among pharma decision-makers.

The agency's core proprietary technology stack centers on Point.1, a data product that covers 80 HCP touchpoints, platforms, and journals — 60% more than competing market offerings — enabling predictive insights into HCP behaviors, attitudes, and channel preferences. Supporting tools include Medi-CX (CX mapping for HCP engagement), Faze1 (clinical trial referral attribution), and Sans Gender (an open-source inclusive-language typeface). Sub-brands include Havas Lynx Media (analytics/media), Faze (clinical trial recruitment), Havas Lynx Medical (medical affairs), Havas Lynx Irwell and Bridgewater (healthcare communications), and Havas Lynx Hudson (US specialist patient communications). The agency has earned recognition at Cannes Lions, Eurobest, Clio Health, IPA Effectiveness, and D&I Awards, and has been named a UK Best Workplace for two consecutive years.

Havas Lynx generates revenue through professional services — project-based fees, retainers, and service contracts with pharma clients — with all engagements custom-scoped and quote-based. Pricing is not publicly disclosed. The business model is horizontal across therapeutic areas and client types, with recent emphasis on AI-related communications, misinformation, and HCP wellbeing themes. In January 2024, the company rebranded from Havas Lynx Group to Havas Lynx, consolidating sub-brands and aligning with parent Havas's visual identity. North America expansion (Havas Lynx New York / Hudson) launched in February 2024 and represents the agency's first major geographic move outside the UK.

Name

Havas Lynx Group

Legal name

Havas Lynx

Website

https://havaslynx.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

251–500 employees

Short description

Havas Lynx is a Manchester-based, Havas Health & You-owned healthcare communications agency with ~600 specialists in the UK and US, serving pharma and biotech clients with creative campaigns, HCP engagement, patient activation, and clinical trial recruitment built on its proprietary Point.1 data platform.

Ownership category

akta.pro rank

Product category

Healthcare Communications

NAICS

Advertising Agencies (541810), Public Relations Agencies (54182)

SIC

Services-Advertising Agencies (7311)

akta.pro primary industry

Brand Campaign & Integrated Communications Agencies (MPAAAAAC)

Keywords

• Healthcare communications
• Pharmaceutical marketing
• Medical education
• Clinical trial recruitment
• Brand strategy services

Headquarters

HQ city

Manchester

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Healthcare Communications Services: Full-service agency model providing campaign development, brand strategy, medical education, creative services, and media planning/execution for pharmaceutical and healthcare brands. Revenue is generated through project-based fees, retainers, and service contracts with pharma clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Havas Lynx Group is a full-service healthcare communications agency providing campaign development, brand strategy, medical education, creative services, media planning/execution, customer experience optimization, and clinical trial recruitment for pharmaceutical companies, biotech firms, and healthcare brands. The agency combines proprietary HCP data insights (Point.1), specialist sub-brands (Faze, Havas Lynx Medical, Havas Lynx Media), and award-winning creative across Manchester, London, and New York offices.

Differentiator

Problem solved

Functional benefit

Brands

• Point.1: Proprietary data product providing comprehensive healthcare professional insights and touchpoint data for pharmaceutical marketing strategies.
• Healing the Healers
• Doctored Truths
• Havas Lynx Medical

Products and services

• Healthcare Communications Services Full-service agency offering covering campaign development, brand strategy, medical education, creative, media planning/buying, HCP engagement, patient activation, and CX optimization for pharmaceutical, biotech, and healthcare brand clients.
• Point.1 Proprietary HCP data and insights platform covering 80 touchpoints, platforms, and journals globally — providing comprehensive HCP attitudes, beliefs, behaviours, and influences for pharmaceutical clients to plan HCP engagement strategies.
• Faze Clinical trial recruitment subsidiary providing patient identification, referral management, and predictive analytics-driven patient recruitment services for pharmaceutical sponsors, supporting more than 450 clinical trials across Europe.
• Havas Lynx Medical Medical affairs and medical education specialization providing scientific communications, publication planning, congress strategy, MSL support, and medical affairs strategy for pharmaceutical clients.
• Havas Lynx Media Analytics, media planning, media buying, and performance offering for healthcare clients.

Quantifiable outcome

• 80% of HCPs concerned about misinformation impact on patients
• +7 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature5 records

Partnerships

Six partnerships are on record, tiered minor.

• American Parkinson Disease Association (APDA)minorStrategic or Co-development Partner · 6 May 2026APDA partnered with Havas Lynx New York for creative support on 'ParkinSex: The Game', a free card game helping couples with Parkinson's navigate physical and emotional intimacy challenges. Havas Lynx contributed creative development alongside input from affected couples, a clinical sexologist, and medical professionals.
• NHS England & Anglia Ruskin UniversityminorStrategic or Co-development Partner · 12 July 2023Havas Lynx co-hosted the NHS Clinical Entrepreneur Programme 'Pitstop' event with NHS England and Anglia Ruskin University, aiming to arm NHS staff with entrepreneurial acumen and foster healthcare innovation. The event featured talks from NHS Innovation Lead, Professor Tony Young, and industry experts including Vernon Bainton (CMO) and Andy Gardner (CSO) from Havas Lynx.
• MysteryVibeminorStrategic or Co-development PartnerHavas Lynx partnered with MysteryVibe, a company that developed the first doctor-designed, FDA-approved intimacy device, for the 'Masturbation as Medicine' campaign. The goal was to reposition masturbation as medicine, highlight health benefits of pleasure, challenge menopause stigma, and empower women to take charge of their sexual wellbeing. The campaign reached 2.3 million people.
• Professor Joyce HarperminorStrategic or Co-development PartnerHavas Lynx collaborated with Professor Joyce Harper (Award-winning Professor of Reproductive Science at Institute for Women's Health, UCL) as a medical expert on the 'Masturbation as Medicine' campaign, providing scientific authority and credibility.
• Europso (European Umbrella Organisation for Psoriasis Movements)minorStrategic or Co-development PartnerHavas Lynx developed the 'Ask Your Derm' global patient activation campaign with patient and professional associations including Europso. The campaign empowers psoriasis patients to ask their dermatologist for clear skin. Endorsed by all European psoriasis associations, it reached over 12 million people in the first 3 months.
• Trinity Life SciencesminorStrategic or Co-development PartnerFaze (Havas Lynx's clinical trial recruitment arm) partnered with Trinity Life Sciences to bring predictive analytics capabilities, helping clients identify the right patients in the right locations to accelerate clinical trial recruitment.

Scale indicators10 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• VCCP Health: UK-rooted healthcare communications agency offering creative and strategy to pharma brands; competes directly in the same UK market and is a former employer of Havas Lynx leadership.
• Fishawack Health (Avalere Health): Global medical, commercial and consulting healthcare agency serving pharma across the product lifecycle, directly comparable to Havas Lynx's integrated medical-plus-creative offering.
• Publicis Health / Langland: Publicis Groupe's healthcare communications arm spanning creative, medical and clinical trial recruitment (Langland), directly overlapping Havas Lynx's full-service and Faze offerings.
• McCann Health (IPG Health): Global healthcare advertising and medical communications network within IPG; directly competes for pharma creative, medical education and HCP engagement mandates, and is a former employer of Havas Lynx's CSO.
• EVERSANA INTOUCH: Full-service healthcare agency network delivering HCP and patient marketing plus commercialization services to pharma, competing in the same category.
• Area 23 / FCB Health (IPG Health): Leading US healthcare advertising agencies within IPG Health, direct competitors to Havas Lynx Hudson's US patient-communications expansion.
• Klick Health: Independent life-sciences commercialization and marketing agency serving pharma HCP and patient audiences, competing directly on integrated creative and data services.
• Evoke (Huntsworth): Health-focused agency group providing creative, media and medical communications to pharma, closely mirroring Havas Lynx's service mix and target clients.
• Real Chemistry: AI-driven health communications company combining data, creative and medical comms for pharma; a direct analog to Havas Lynx's data-plus-creative Point.1 model.

Broad incumbents

• Omnicom Health Group: One of the largest healthcare marketing networks, offering overlapping creative, media and medical services across a far wider portfolio and geography than Havas Lynx.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=m9q7Jxgb4yA
• LinkedInlinkedin.com/company/havaslynx
• Xx.com/havaslynxeu

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Havas Lynx Group